Central Nervous System
Amicus receives FDA approval for Pompe disease therapy
Amicus Therapeutics has received approval from the US Food and Drug Administration (FDA) for a two-component therapy, Pombiliti (cipaglucosidase alfa-atga)…
Fabre-Kramer gains FDA approval for major depressive disorder therapy
Fabre-Kramer Pharmaceuticals has obtained approval from the US Food and Drug Administration (FDA) for Exxua (gepirone hydrochloride extended-release tablets) to…
Roche gains rights to Ionis’ Alzheimer’s and Huntington’s programmes
Roche has signed an agreement to attain exclusive global rights to Ionis Pharmaceuticals’ two early-stage programmes for Alzheimer’s disease and Huntington’s disease…
Tetra receives rare paediatric disease designation for FXS therapy
Shionogi Group company Tetra Therapeutics has received rare paediatric disease designation from the US Food and Drug Administration (FDA) for…
Yale and Transcend wins US DoD grant for PTSD therapy
The US Department of Defense has awarded a collaborative grant to Transcend Therapeutics and Yale University (US). The grant is…
Pharmanovia announces acquisition of Sanofi’s CNS brands
UK-based Pharmanovia has announced the acquisition of 11 central nervous system (CNS) brands from Sanofi. The brands are intended for…
NICE recommends Idorsia’s chronic insomnia treatment for UK patients
Adults in England and Wales with insomnia will have access to a new treatment on the NHS after the therapy's…
Cure Genetics and Frametact seek gene cures for neurological ailments
China-based clinical-stage company Cure Genetics has entered a partnership and licensing deal with biotech company Frametact to develop gene therapy for familial neurological…
NICE recommends use of Vydura for acute migraines on the NHS
Adults in England and Wales with acute migraines will now have access to a new treatment after the National Institute…
Pharmazz and Sun Pharma sign licence deal for Tyvalzi launch in India
Biopharmaceutical company Pharmazz and Sun Pharmaceutical Industries have signed a licence agreement for the marketing of Tyvalzi (Sovateltide) in India. Pharmazz…